GSK Plc ADR [GSK] stock prices are up 2.09% to $42.49 at the moment. It is a good measure of the stock’s recent performance to check whether the stock’s short-term value is rising or falling. The GSK shares have gain 3.26% over the last week, with a monthly amount glided 16.89%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
GSK Plc ADR [NYSE: GSK] stock has seen the most recent analyst activity on June 03, 2025, when Berenberg downgraded its rating to a Hold. Previously, Exane BNP Paribas started tracking the stock with Neutral rating on April 15, 2025, and set its price target to $35.25. On February 12, 2025, Morgan Stanley initiated with a Equal-Weight rating. Deutsche Bank downgraded its rating to a Hold. Jefferies downgraded its rating to a Hold and reduced its price target to $39.50 on November 12, 2024. Guggenheim downgraded its rating to Neutral for this stock on October 31, 2024. In a note dated July 08, 2024, UBS downgraded an Neutral rating on this stock.
The stock price of GSK Plc ADR [GSK] has been fluctuating between $31.72 and $44.67 over the past year. Currently, Wall Street analysts expect the stock to reach $35.25 within the next 12 months. GSK Plc ADR [NYSE: GSK] shares were valued at $42.49 at the most recent close of the market. An investor can expect a potential drop of -17.04% based on the average GSK price forecast.
Analyzing the GSK fundamentals
The GSK Plc ADR [NYSE:GSK] reported sales of 40.23B for trailing twelve months, representing a surge of 1.38%. Gross Profit Margin for this corporation currently stands at 0.72% with Operating Profit Margin at 0.16%, Pretax Profit Margin comes in at 0.13%, and Net Profit Margin reading is 0.1%. To continue investigating profitability, this company’s Return on Assets is posted at 0.05, Equity is 0.22 and Total Capital is 0.13. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 1.3.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance.
Ratios To Look Out For
It’s worth pointing out that GSK Plc ADR [NYSE:GSK]’s Current Ratio is 0.87. Further, the Quick Ratio stands at 0.58, while the Cash Ratio is 0.21. Considering the valuation of this stock, the price to sales ratio is 2.14, the price to book ratio is 4.75 and price to earnings (TTM) ratio is 22.06.
Transactions by insiders
Recent insider trading involved GSK plc, 10% Owner, that happened on Sep 27 ’24 when 2.79 million shares were purchased.
